Skip to main content

IGF-1 LR3 vs Cerebrolysin

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

IGF-1 LR3

IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is a modified version of IGF-1 with extended half-life and enhanced potency. The modifications prevent binding to IGF binding proteins, increasing bioavailability.

Full details →

Cerebrolysin

Cerebrolysin is a mixture of low-molecular-weight neuropeptides and free amino acids derived from purified pig brain proteins. It is approved in many countries for stroke, traumatic brain injury, and dementia.

Full details →

Side-by-Side Comparison

AspectIGF-1 LR3Cerebrolysin
MechanismBinds to IGF-1 receptors to promote protein synthesis, muscle growth, and fat metabolism. The LR3 modification (13 amino acid extension and arginine substitution) extends half-life from minutes to 20-30 hours.Contains multiple neurotrophic factors that promote neuroplasticity, reduce neuronal apoptosis, and support synaptic function. Has both neurotrophic and neuroprotective properties.
Typical DosageResearch protocols typically use 20-100mcg daily, often divided into multiple injections or administered bilaterally to target muscles.Clinical dosing: 10-30ml IV daily for acute conditions. Research use: 5-10ml IM daily for cognitive enhancement. Treatment courses typically last 10-20 days.
AdministrationIntramuscular injection (site-specific growth) or subcutaneous for systemic effects. Often cycled 4-6 weeks on, equal time off.Administered via intramuscular or intravenous injection. IV administration is typically used in clinical settings. IM can be used for research purposes.
Side EffectsHypoglycemia, joint pain, water retention, potential jaw/hand growth with extended use, and injection site reactions.Generally well-tolerated. May cause dizziness, headache, sweating, or injection site reactions. Rare cases of agitation or confusion.
Best For

What They Have in Common

Both IGF-1 LR3 and Cerebrolysin are commonly used for:

Key Differences

Unique to IGF-1 LR3:

Unique to Cerebrolysin:

Ready to Learn More?